Skip to main content
. 2021 Dec 8;9:769881. doi: 10.3389/fcell.2021.769881

FIGURE 3.

FIGURE 3

Survival for patients with low-risk and high-risk subtypes. (A) Overall survival; (B) disease-free survival. Survival for patients with GGOs and pure solid nodules. (C) Overall survival; (D) disease-free survival.